Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Statins beneficial for diabetics

This article was originally published in The Tan Sheet

Executive Summary

Statin therapy is safe and cost-effective option for reducing the risk of major vascular events in patients with diabetes and should be considered for almost all diabetics, according to a meta-analysis by the Cholesterol Treatment Trialists' Collaborators. The study, which was published in The Lancet Jan. 12 and included 14 trials with 18,686 diabetics and 17,220 non-diabetics, found statin therapy in diabetics was associated with a 9 percent proportional reduction in all-cause mortality per mmol/L reduction in LDL cholesterol, and was associated with a statistically similar 13 percent reduction in all-cause mortality in those without diabetes...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS101402

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel